( 02171.hk)
市盈率-16.54市净率8.69股息率0%上市时间2021-06-18股价15.84港币涨跌幅-3.83%成交金额2,222.23万港币换手率0.24%市值91.55亿港币H股市值91.55亿港币总股本5.78亿H股本5.78亿每手股数500上市至今年化投资收益率-13.09%港股通持仓占H股比例18.91% (16.23亿港币2025-12-31) 累计做空占H股比例3.12% (2.72亿港币2025-12-24)
所属三级行业生物技术 (恒生) 市盈率65.41市净率4.96股息率0.31%恒生:医疗保健业药品及生物科技生物技术
备注 (4): 双击编辑备注
发表讨论

科济药业-B(02171) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1趙向可Independent Non Executive Director - A/F2023-07-04--
2李華兵Independent Non Executive Director2023-03-09--
3蔣華Executive Director2022-08-01--
4顏光美Independent Non Executive Director2021-06-18--
5蘇德揚Independent Non Executive Director - A/F2021-06-182023-06-30
6樊春海Independent Non Executive Director2021-06-182023-01-11
7郭華清Non Executive Director2020-09-18--
8謝榕剛Non Executive Director2020-09-18--
9郭炳森Non Executive Director2018-09-13--
10王華茂Executive Director2018-09-13--
11趙雅超Non Executive Director2018-09-132022-05-27
12李宗海Executive Director2018-02-09--